Japanese researchers have started clinical trials to explore the effectiveness and safety of universal artificial blood, which could have a shelf life of up to two years and save millions of lives. Artificial blood, created by encapsulating haemoglobin, the protein that carries oxygen has been made from expired blood within a protective shell, forming haemoglobin vesicles (HbVs).